Page last updated: 2024-08-23

phenyl acetate and ro 48-3657

phenyl acetate has been researched along with ro 48-3657 in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	2 (66.67)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alig, L; Beresini, M; Blackburn, B; Bunting, S; Hadváry, P; Knopp, D; Levet-Trafit, B; Lipari, MT; Modi, NB; Müller, M; Müller, MH; Refino, CJ; Schmitt, M; Schönholzer, P; Steiner, B; Weiss, S; Weller, T	1
Jang, IK; Sabatine, MS	1
Bachmann, LM; Golder, S; Kleijnen, J; McDonagh, MS; ter Riet, G	1

Reviews

2 review(s) available for phenyl acetate and ro 48-3657

Article	Year
The use of glycoprotein IIb/IIIa inhibitors in patients with coronary artery disease. The American journal of medicine, 2000, Aug-15, Volume: 109, Issue:3 Topics: Abciximab; Acetates; Acute Disease; Administration, Oral; Alanine; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Benzamidines; Coronary Disease; Eptifibatide; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Oximes; Peptides; Piperidines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyrrolidines; Randomized Controlled Trials as Topic; Stents; Syndrome; Thrombocytopenia; Thrombolytic Therapy; Tirofiban; Tyrosine	2000
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of glycoprotein IIb/IIIa antagonists in the medical management of unstable angina. Health technology assessment (Winchester, England), 2000, Volume: 4, Issue:30 Topics: Acetates; Angina, Unstable; Biphenyl Compounds; Cost-Benefit Analysis; Eptifibatide; Female; Humans; Male; Oximes; Peptides; Piperidines; Platelet Aggregation Inhibitors; Pyrrolidines; Tirofiban; Tyrosine	2000

Article

Year

The use of glycoprotein IIb/IIIa inhibitors in patients with coronary artery disease.

The American journal of medicine, 2000, Aug-15, Volume: 109, Issue:3

Topics: Abciximab; Acetates; Acute Disease; Administration, Oral; Alanine; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Benzamidines; Coronary Disease; Eptifibatide; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Oximes; Peptides; Piperidines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyrrolidines; Randomized Controlled Trials as Topic; Stents; Syndrome; Thrombocytopenia; Thrombolytic Therapy; Tirofiban; Tyrosine

2000

A rapid and systematic review of the clinical effectiveness and cost-effectiveness of glycoprotein IIb/IIIa antagonists in the medical management of unstable angina.

Health technology assessment (Winchester, England), 2000, Volume: 4, Issue:30

Topics: Acetates; Angina, Unstable; Biphenyl Compounds; Cost-Benefit Analysis; Eptifibatide; Female; Humans; Male; Oximes; Peptides; Piperidines; Platelet Aggregation Inhibitors; Pyrrolidines; Tirofiban; Tyrosine

2000

Other Studies

1 other study(ies) available for phenyl acetate and ro 48-3657

Article	Year
Orally active fibrinogen receptor antagonists. 2. Amidoximes as prodrugs of amidines. Journal of medicinal chemistry, 1996, Aug-02, Volume: 39, Issue:16 Topics: Acetates; Administration, Oral; Amidines; Animals; Anticoagulants; Dogs; Macaca mulatta; Magnetic Resonance Spectroscopy; Mass Spectrometry; Mice; Molecular Structure; Oximes; Piperidines; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prodrugs; Rats; Tyrosine	1996

Article

Year

Orally active fibrinogen receptor antagonists. 2. Amidoximes as prodrugs of amidines.

Journal of medicinal chemistry, 1996, Aug-02, Volume: 39, Issue:16

Topics: Acetates; Administration, Oral; Amidines; Animals; Anticoagulants; Dogs; Macaca mulatta; Magnetic Resonance Spectroscopy; Mass Spectrometry; Mice; Molecular Structure; Oximes; Piperidines; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prodrugs; Rats; Tyrosine

1996